Diabetes, Vol 48, Issue 5 1145-1155, Copyright © 1999 by American Diabetes Association

ARTICLES

Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway

Y Hata, SL Rook and LP Aiello
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.

Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are angiogenic molecules whose combined mitogenic activity is potently synergistic. However, the molecular mechanism underlying this synergy is incompletely understood. We examined whether VEGF and bFGF affect expression of each other or alter expression of the VEGF receptor KDR in retinal capillary endothelial cells. In addition, we investigated the intracellular signaling mechanisms involved in this response. VEGF-induced [3H]thymidine uptake was tightly correlated with KDR mRNA and protein concentrations, suggesting that increased KDR expression might account for VEGF's synergistic activity in the presence of bFGF. bFGF (10 ng/ml) induced KDR mRNA expression within 4 h and attained a 4.0-fold increase after 24 h. KDR protein expression was increased 7.5-fold after 48 h. VEGF (= 50 ng/ml) did not alter bFGF, VEGF, or KDR mRNA expression under serum-deprived conditions. In contrast, VEGF increased KDR mRNA expression 87% under growth conditions and 2.9-fold under serum-deprived conditions in the presence of bFGF. The protein kinase C (PKC) agonist phorbol myristate acetate (PMA) induced KDR mRNA expression 5.1-fold at 100 nmol/l. bFGF increased p44/p42 mitogen-activated protein kinase (MAPK) phosphorylation within 5 min, reaching a maximum within 15 min and remaining significantly elevated for >6 h. bFGF-induced MAPK phosphorylation and KDR mRNA expression were almost completely inhibited by 5 micromol/l GFX, a non-isoform-selective PKC inhibitor. MAPK inhibitor PD98059 reduced KDR mRNA expression 72% at concentrations that inhibited bFGF-induced MAPK phosphorylation 100%, suggesting that pathways in addition to MAPK might also be involved. Inhibitors of the beta isoform of PKC (LY333531), protein kinase A (PKA) (H89), and phosphotidylinositol (PI) 3 kinase (wortmannin) had no significant effect. These data suggest that bFGF stimulates KDR expression through a PKC and p44/p42 MAPK-dependent pathway not primarily involving the beta isoform of PKC, PKA, or PI-3 kinase. Since bFGF induces VEGF expression and since increased KDR expression potentiates VEGF action, resulting in additional KDR expression and marked mitogenic activity, these data provide a novel mechanistic explanation for the angiogenic synergy between VEGF and bFGF.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Kita, Y. Hata, M. Miura, S. Kawahara, S. Nakao, and T. Ishibashi Functional Characteristics of Connective Tissue Growth Factor on Vitreoretinal Cells Diabetes, May 1, 2007; 56(5): 1421 - 1428. [Abstract] [Full Text] [PDF]

				X.-F. Wang, J. Z. Cui, S. S. Prasad, and J. A. Matsubara Altered Gene Expression of Angiogenic Factors Induced by Calcium-Mediated Dissociation of Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1508 - 1515. [Abstract] [Full Text] [PDF]

				K. Hirayama, Y. Hata, Y. Noda, M. Miura, I. Yamanaka, H. Shimokawa, and T. Ishibashi The Involvement of the Rho-Kinase Pathway and Its Regulation in Cytokine-Induced Collagen Gel Contraction by Hyalocytes Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3896 - 3903. [Abstract] [Full Text] [PDF]

				Y. Noda, Y. Hata, T. Hisatomi, Y. Nakamura, K. Hirayama, M. Miura, S. Nakao, K. Fujisawa, T. Sakamoto, and T. Ishibashi Functional Properties of Hyalocytes under PDGF-Rich Conditions Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2107 - 2114. [Abstract] [Full Text] [PDF]

				Y. Oshima, K. Sato, F. Tashiro, J.-i. Miyazaki, K. Nishida, Y. Hiraki, Y. Tano, and C. Shukunami Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I J. Cell Sci., June 1, 2004; 117(13): 2731 - 2744. [Abstract] [Full Text] [PDF]

				G. Boguslawski, P. W. McGlynn, K. A. Harvey, and A. T. Kovala SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Causes Accumulation of Phosphorylated ERK Kinases and Inhibits Their Activity in Vivo and in Vitro J. Biol. Chem., February 13, 2004; 279(7): 5716 - 5724. [Abstract] [Full Text] [PDF]

				C. K. Chan, L. N. Pham, C. Chinn, C. Spee, S. J. Ryan, R. J. Akhurst, and D. R. Hinton Mouse Strain-Dependent Heterogeneity of Resting Limbal Vasculature Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 441 - 447. [Abstract] [Full Text] [PDF]

				O. Kessler, N. Shraga-Heled, T. Lange, N. Gutmann-Raviv, E. Sabo, L. Baruch, M. Machluf, and G. Neufeld Semaphorin-3F Is an Inhibitor of Tumor Angiogenesis Cancer Res., February 1, 2004; 64(3): 1008 - 1015. [Abstract] [Full Text] [PDF]

				X. Jiang and J. R. Couchman Perlecan and Tumor Angiogenesis J. Histochem. Cytochem., November 1, 2003; 51(11): 1393 - 1410. [Abstract] [Full Text] [PDF]

				J. L. Wilkinson-Berka, N. S. Alousis, D. J. Kelly, and R. E. Gilbert COX-2 Inhibition and Retinal Angiogenesis in a Mouse Model of Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 974 - 979. [Abstract] [Full Text] [PDF]

				C. Cohen, A. Zavala-Pompa, J. H. Sequeira, M. Shoji, D. G. Sexton, G. Cotsonis, F. Cerimele, B. Govindarajan, N. Macaron, and J. L. Arbiser Mitogen-actived Protein Kinase Activation Is an Early Event in Melanoma Progression Clin. Cancer Res., December 1, 2002; 8(12): 3728 - 3733. [Abstract] [Full Text] [PDF]

				M. Onimaru, Y. Yonemitsu, M. Tanii, K. Nakagawa, I. Masaki, S. Okano, H. Ishibashi, K. Shirasuna, M. Hasegawa, and K. Sueishi Fibroblast Growth Factor-2 Gene Transfer Can Stimulate Hepatocyte Growth Factor Expression Irrespective of Hypoxia-Mediated Downregulation in Ischemic Limbs Circ. Res., November 15, 2002; 91(10): 923 - 930. [Abstract] [Full Text] [PDF]

				T. Abumiya, T. Sasaguri, Y. Taba, Y. Miwa, and M. Miyagi Shear Stress Induces Expression of Vascular Endothelial Growth Factor Receptor Flk-1/KDR Through the CT-Rich Sp1 Binding Site Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 907 - 913. [Abstract] [Full Text] [PDF]

				H. Zhang and A. C. Issekutz Down-Modulation of Monocyte Transendothelial Migration and Endothelial Adhesion Molecule Expression by Fibroblast Growth Factor : Reversal by the Anti-Angiogenic Agent SU6668 Am. J. Pathol., June 1, 2002; 160(6): 2219 - 2230. [Abstract] [Full Text] [PDF]

				S R Boyd, D S W Tan, L de Souza, M H Neale, N E Myatt, R A Alexander, M Robb, J L Hungerford, and I A Cree Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth Br. J. Ophthalmol., April 1, 2002; 86(4): 440 - 447. [Abstract] [Full Text] [PDF]

				G. Gao, Y. Li, S. Gee, A. Dudley, J. Fant, C. Crosson, and J.-x. Ma Down-regulation of Vascular Endothelial Growth Factor and Up-regulation of Pigment Epithelium-derived Factor. A POSSIBLE MECHANISM FOR THE ANTI-ANGIOGENIC ACTIVITY OF PLASMINOGEN KRINGLE 5 J. Biol. Chem., March 8, 2002; 277(11): 9492 - 9497. [Abstract] [Full Text] [PDF]

				I. Suzuma, Y. Hata, A. Clermont, F. Pokras, S. L. Rook, K. Suzuma, E. P. Feener, and L. P. Aiello Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor--2: Potential Mechanisms for Exacerbation of Diabetic Retinopathy by Hypertension Diabetes, February 1, 2001; 50(2): 444 - 454. [Abstract] [Full Text]

				R. A. Mesa, C. A. Hanson, S. V. Rajkumar, G. Schroeder, and A. Tefferi Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia Blood, November 15, 2000; 96(10): 3374 - 3380. [Abstract] [Full Text] [PDF]

				W. Cai, S. L. Rook, Z. Y. Jiang, N. Takahara, and L. P. Aiello Mechanisms of Hepatocyte Growth Factor-Induced Retinal Endothelial Cell Migration and Growth Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1885 - 1893. [Abstract] [Full Text]

				S.-F. Yan, J. Lu, Y. S. Zou, W. Kisiel, N. Mackman, M. Leitges, S. Steinberg, D. Pinsky, and D. Stern Protein Kinase C-beta and Oxygen Deprivation. A NOVEL Egr-1-DEPENDENT PATHWAY FOR FIBRIN DEPOSITION IN HYPOXEMIC VASCULATURE J. Biol. Chem., April 14, 2000; 275(16): 11921 - 11928. [Abstract] [Full Text] [PDF]

				R. J. Tomanek, A. Sandra, W. Zheng, T. Brock, R. J. Bjercke, and J. S. Holifield Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Differentially Modulate Early Postnatal Coronary Angiogenesis Circ. Res., June 8, 2001; 88(11): 1135 - 1141. [Abstract] [Full Text] [PDF]